The CAR macrophages targeting c-Met exhibit potential therapeutic effects in inhibiting angiogenesis mimicry in pancreatic cancer, providing new directions for the research and treatment of pancreatic cancer and other solid tumors. This evidence concerns the gene MET and pancreatic neoplasm.